S2k guideline on diagnosis and treatment of atopic dermatitis - short version
Standard
S2k guideline on diagnosis and treatment of atopic dermatitis - short version. / Werfel, Thomas; Heratizadeh, Annice; Aberer, Werner; Ahrens, Frank; Augustin, Matthias; Biedermann, Tilo; Diepgen, Thomas; Fölster-Holst, Regina; Gieler, Uwe; Kahle, Julia; Kapp, Alexander; Nast, Alexander; Nemat, Katja; Ott, Hagen; Przybilla, Bernhard; Roecken, Martin; Schlaeger, Martin; Schmid-Grendelmeier, Peter; Schmitt, Jochen; Schwennesen, Thomas; Staab, Doris; Worm, Margitta.
in: Allergo J Int, Jahrgang 25, Nr. 3, 31.05.2016, S. 82-95.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - S2k guideline on diagnosis and treatment of atopic dermatitis - short version
AU - Werfel, Thomas
AU - Heratizadeh, Annice
AU - Aberer, Werner
AU - Ahrens, Frank
AU - Augustin, Matthias
AU - Biedermann, Tilo
AU - Diepgen, Thomas
AU - Fölster-Holst, Regina
AU - Gieler, Uwe
AU - Kahle, Julia
AU - Kapp, Alexander
AU - Nast, Alexander
AU - Nemat, Katja
AU - Ott, Hagen
AU - Przybilla, Bernhard
AU - Roecken, Martin
AU - Schlaeger, Martin
AU - Schmid-Grendelmeier, Peter
AU - Schmitt, Jochen
AU - Schwennesen, Thomas
AU - Staab, Doris
AU - Worm, Margitta
N1 - Behandlungsleitlinie
PY - 2016/5/31
Y1 - 2016/5/31
N2 - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).
AB - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).
KW - Review
KW - Journal Article
U2 - 10.1007/s40629-016-0110-8
DO - 10.1007/s40629-016-0110-8
M3 - Other (editorial matter etc.)
C2 - 27239428
VL - 25
SP - 82
EP - 95
JO - Allergo J Int
JF - Allergo J Int
SN - 2197-0378
IS - 3
ER -